NASDAQ:TLRY

Tilray Inc. (TLRY)

5.15
+0.04 (0.78%)
as of Jun 4, 2026, 1:31:23 pm Market Open.
90 watching
0
Investor Insights
star iconJun 3, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

Tilray Inc. (TLRY-Q) has recently faced some challenging financial metrics, with reported revenues experiencing notable declines. In the latest quarter, the company saw a revenue of $288 million, reflecting a -6.6% drop from the previous quarter, while gross profit decreased by 14.9%, totaling $79 million. Another report highlighted an even steeper revenue decline, with figures falling to $210 million, a -32% change. This decline in both revenue and gross profit raises concerns regarding demand for Tilray's products and potentially indicates market challenges. Despite these issues, social media mentions have surged by over 28% in the last day, suggesting a rising interest that may not yet be reflected in financial performance. Investors are advised to look towards the U.S. market for potentially better opportunities and to consider using their current holdings for tax loss purposes.

consensus icon
Consensus
Sell
valuation icon
Valuation
Overvalued
review icon
Similar
Organigram,OGI
DON'T BUY
It reports Monday. Pot stocks have been devastating. Since 2018, this has been all downhill. Let's see if the CEO can change direction.
BUY ON WEAKNESS
Bullish on medical marijuana. We will see legalizing banking in the US for the sector. There will be volatility. He sold into strength. Likes it here. Has lots of upside potential.
COMMENT
It will be a big industry that will be huge in the future. There is still 30%-50% upside in the future. The question should be whether you would add new money or not. If you do not want to , it is time to cash out.
DON'T BUY
There's lower highs and lower lows. He would look elsewhere for better potential.
DON'T BUY
He would not buy this. It collapsed from $350. Not the story he invests in. A long term story, hopefully with another couple years of losses yet to come. Too risky for him.
COMMENT
There is some downside pressure on HMMJ-T. At the $14 or $17 range there is resistance. Who knows what the effect would be if the government changes in October. [Caller asked about TLRY] He sees $34 as a target on TLRY-T as there is nothing to hold it higher.
Showing 16 to 22 of 22 entries